AI-powered Clinical Insights

Scientific Research

At Enbiosis, we believe that science is the foundation of health. 

All of our AI-powered microbiome solutions are backed by peer-reviewed clinical research published in top-tier scientific journals.  

Our studies demonstrate measurable improvements in gut health, validated by independent trials in the fields of gastroenterology, microbiology, and nutritional science

Published Studies

Irritable Bowel Syndrome

Published in: The American Journal  of Gastroenterology

121 IBS patients | 96 showed improvement with AI-personalized diet

Effective across all IBS types (Constipation, Diarrhea, Mixed)

Impact Factor: 10.9 | H-index: 286

Chronic Constipation

Published in: Journal of Clinical Medicine

45 patients with chronic constipation

84% achieved 3+ bowel movements per week within 6 weeks

AI-assisted nutrition plan

Impact Factor: 5.1 | H-index: 75

IBS Symptom Score  & Microbiome Changes

Published in: Gut Microbes

Pilot study on 25 patients

Symptom score reduced by 124 points

Increased Faecalibacterium and Propionibacterium

Impact Factor: 11.7 | H-index: 82

Probiotic  Supplement Accuracy

Published in: Molecular Nutrition  & Food Researchp

50 US probiotic products analyzed

1 in 3 had inaccurate labels 

Advocates for stricter  probiotic regulation

Impact Factor: 6.5 | H-index: 160

Upcoming Research

We are currently working on several new clinical trials focused on

Study of the efficacy of a personalised diet in eczema

Dry Eye Disease clinical study

Age-Related Macular Degeneration (AMD) clinical study

Open to research partnerships

These studies are being conducted in collaboration with leading research hospitals and institutions, and results will be published in Q2–Q4 of 2025.

Stay tuned for more science-backed breakthroughs.

Want to partner with us or get early access to our clinical data?